A $44 million superhero horror film won the box office this weekend. A $7 million documentary came within $5 million of beating it

A24’s You Can See Everything rose 25% in its second weekend to $19.5 million, taking its domestic total to $45.1 million after expanding to 2,655 theaters; its reported production budget is about $7 million. Clayface led the weekend with $24.5 million, below its studio projection of $25 million–$30 million, while Street Fighter fell 72% to $8.6 million. Total weekend box office was $94.9 million, up nearly 22% from the same weekend in 2025, and year-to-date ticket sales reached $8.4 billion, about 20% ahead of last year’s pace.

Analysis

The more useful signal is about content economics, not a single weekend’s ranking. A low-budget, adult-oriented release that broadens beyond an opening-weekend fan base supports the case for selective theatrical bets where downside is capped and word of mouth can extend the run. That is a potential strategic positive for Warner Bros. Discovery’s slate discipline, but one film is not evidence of a durable hit rate or a material consolidated earnings change. The under-projection opening for Clayface is a modest negative headline; its reported production budget limits the obvious downside versus a costly tentpole, though distribution, marketing and exhibitor economics are not provided.

Paramount Skydance faces the opposite read-through from Street Fighter’s sharp second-week decline: franchise recognition can produce a large opening without durable demand. Treat this as a title-level warning, not a basis to extrapolate across the company’s slate. The relative performance also suggests audience demand is not simply migrating to recognizable IP; distinctive documentaries can compete for screens and attention, potentially raising the bar for mid-budget releases.

Near term, weaker weekend releases and an awards narrative could sustain attention for the documentary, but awards prospects are speculative and a quieter calendar can distort comparisons. Over 1–3 months, screen retention, weekly grosses and international performance matter more than the opening. Over 6–18 months, the test is whether studios repeat lower-cost, differentiated theatrical investments. Box-office results alone do not establish meaningful earnings sensitivity for either mapped company. Verify the article’s corporate-transaction language and reporting perimeter before attributing any results across Paramount Skydance and Warner Bros. Discovery.

Key Decisions for Investors

• No immediate directional trade in WBD or PSKY on this data alone: the box-office signal is title-specific, and the article provides no distribution terms, marketing spend, profit participation or company-level earnings sensitivity.
• Watch WBD for a potential sentiment-driven entry only if the market overreacts to Clayface’s opening versus expectations while subsequent weekly grosses and cost disclosures remain consistent with a contained-budget outcome. Thesis is falsified by a steep second-week collapse or evidence that all-in costs materially exceed the reported production budget.
• Use Street Fighter as a slate-quality watch item for PSKY, not a short trigger. Reassess if the decline is followed by weaker-than-expected downstream performance or company guidance changes; a single title’s drop does not establish a broader franchise or studio impairment.
• Track the documentary’s next 2–3 weekends, theater count, per-theater gross, international rollout and awards traction. Sustained attendance outside its initial audience would strengthen the lower-cost differentiated-content thesis; rapid screen losses would weaken it. Separately verify the claimed merger and which entity bears the relevant studio results before making cross-company attribution.